Pulmonary fibrosis is a chronic and progressive lung disease marked by abnormal scarring of the tissue surrounding the air sacs. This process thickens and stiffens the lungs, leading to shortness of breath, fatigue, and reduced oxygen exchange. Current medications, such as pirfenidone and nintedanib, can slow disease progression but do not reverse tissue damage. As…
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease that causes irreversible damage to the alveoli and leads to pulmonary interstitial fibrosis. Patients with IPF often experience severe difficulty breathing, which can result in respiratory failure and death. The disease is challenging to diagnose, has a high mortality rate, and a median survival of…
Chronic obstructive pulmonary disease affects 16 million adults in the United States, according to the National Heart, Lung, and Blood Institute. COPD refers to two main conditions — chronic bronchitis and emphysema. If you’ve received a COPD diagnosis, it can be tough to know what to expect from the disease as it progresses. For many people,…
We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!